Human epicardial adipose tissue: a review.

We discuss the anatomy, physiology, and pathophysiology of epicardial adipose tissue and its relationship to coronary atherosclerosis. Epicardial fat stores triglyceride to supply free fatty acids for myocardial energy production and produces adipokines. It shares a common embryological origin with mesenteric and omental fat. Like visceral abdominal fat, epicardial fat thickness, measured by echocardiography, is increased in obesity. Epicardial fat could influence coronary atherogenesis and myocardial function because there is no fibrous fascial layer to impede diffusion of free fatty acids and adipokines between it and the underlying vessel wall as well as the myocardium. Segments of coronary arteries lacking epicardial fat or separated from it by a bridge of myocardial tissue are protected against the development of atherosclerosis in those segments. However, when epicardial fat is totally absent in congenital generalized lipodystrophy, coronary atherosclerosis can still occur. Macrophages are more numerous and densely packed in the periadventitial fat of human atherosclerotic coronary arteries with lipid cores than in that of fibrocalcific or nonatherosclerotic coronary arteries. In obese patients with multiple cardiovascular risk factors, epicardial fat around atheromatous coronaries secretes several proinflammatory cytokines and is infiltrated by macrophages, lymphocytes, and basophils. Epicardial adipokine expression in obesity without coronary atherosclerosis has not been determined. In nonobese patients, epicardial fat around atheromatous coronary arteries expresses proinflammatory cytokines but produces either less adiponectin, a vasoprotective adipokine, than fat around nonatheromatous coronaries or a similar amount compared with thoracic subcutaneous fat. Further studies should be done to test the hypothesis that adipokines produced by and released from human epicardial adipose tissue might contribute locally to the pathogenesis of coronary atherosclerosis.

[1]  A. Greenberg,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .

[2]  C. Peterson,et al.  Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. , 2005, Diabetes.

[3]  R. Scully,et al.  Case records of the Massachusetts General Hospital. , 1990 .

[4]  F. Leonetti,et al.  Relation between epicardial adipose tissue and left ventricular mass. , 2004, The American journal of cardiology.

[5]  J. Kroustrup,et al.  Comparison of Gene Expression in Intra‐Abdominal and Subcutaneous Fat: A Study of Men with Morbid Obesity and Nonobese Men Using Microarray and Proteomics , 2004, Annals of the New York Academy of Sciences.

[6]  Harry L. Smith,et al.  ADIPOSITY OF THE HEART: A CLINICAL AND PATHOLOGIC STUDY OF ONE HUNDRED AND THIRTY-SIX OBESE PATIENTS , 1933 .

[7]  C. Pond,et al.  Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. , 1990, International journal of obesity.

[8]  Domenico Corradi,et al.  Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart , 2005, Nature Clinical Practice Cardiovascular Medicine.

[9]  Carl D Langefeld,et al.  Pericardial and Visceral Adipose Tissues Measured Volumetrically With Computed Tomography Are Highly Associated in Type 2 Diabetic Families , 2005, Investigative radiology.

[10]  G. Iacobellis Imaging of visceral adipose tissue: an emerging diagnostic tool and therapeutic target. , 2005, Current drug targets. Cardiovascular & haematological disorders.

[11]  M. Chandalia,et al.  Postmortem findings in congenital generalized lipodystrophy. , 1995, The Journal of clinical endocrinology and metabolism.

[12]  S. Svacina,et al.  Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. , 2006, The Journal of clinical endocrinology and metabolism.

[13]  A. Lerman,et al.  Myocardial Uptake of Circulating Triglycerides in Nondiabetic Patients With Heart Disease , 2007, Diabetes.

[14]  B. Goldstein,et al.  Adiponectin: A novel adipokine linking adipocytes and vascular function. , 2004, The Journal of clinical endocrinology and metabolism.

[15]  Ronald A. Arky,et al.  Case 1-1975 , 1975 .

[16]  K. L. Moore,et al.  The Developing Human: Clinically Oriented Embryology , 1973 .

[17]  J. Schaffer,et al.  Lipotoxicity: when tissues overeat , 2003, Current opinion in lipidology.

[18]  P. Scherer From Lipid Storage Compartment to Endocrine Organ , 2006 .

[19]  B. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.

[20]  S. Brichard Adiponectin and the metabolic syndrome , 2005 .

[21]  R. Eckel,et al.  Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease. , 2002, Circulation.

[22]  E L Ritman,et al.  Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. , 1998, The Journal of clinical investigation.

[23]  R. Cury,et al.  Mapping epicardial fat with multi-detector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation. , 2006, European journal of radiology.

[24]  L. Orci,et al.  Lipotoxic heart disease in obese rats: implications for human obesity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H. Gray Gray's Anatomy , 1858 .

[26]  Aloke V. Finn,et al.  Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[27]  A. Madan,et al.  Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. , 2004, American journal of physiology. Endocrinology and metabolism.

[28]  K. Williams,et al.  Lipoprotein retention--and clues for atheroma regression. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[29]  R. Benza,et al.  Acute take-off of the right coronary artery with long intra-aortic wall course presenting as chronic coronary ostium occlusion in a patient with end-stage heart failure. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  T. Suganami,et al.  A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor α , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[31]  B. Ambrosi,et al.  Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity. , 2007, International journal of cardiology.

[32]  A. Madan,et al.  Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. , 2004, Endocrinology.

[33]  Johan Auwerx,et al.  Depot-Specific Differences in Adipose Tissue Gene Expression in Lean and Obese Subjects , 1998, Diabetes.

[34]  S. Toubro,et al.  Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. , 2003, European journal of endocrinology.

[35]  Y. Ishikawa,et al.  Absence of atherosclerosis evolution in the coronary arterial segment covered by myocardial tissue in cholesterol-fed rabbits , 1997, Virchows Archiv.

[36]  K. Williams,et al.  The response-to-retention hypothesis of atherogenesis reinforced. , 1998, Current opinion in lipidology.

[37]  S. Toubro,et al.  Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. , 2003, American journal of physiology. Endocrinology and metabolism.

[38]  M. Naghavi,et al.  The role of periadventitial fat in atherosclerosis. , 2007, Archives of pathology & laboratory medicine.

[39]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[40]  Paul Poirier,et al.  Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism , 2006, Circulation.

[41]  X. Fang,et al.  Isolation and characterization of human epicardial adipocytes: potential role in vascular inflammation , 2006 .

[42]  P. Scherer Adipose Tissue , 2006, Diabetes.

[43]  J. Parks,et al.  Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects African green monkeys from coronary artery atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[44]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[45]  S. Gordon Macrophage heterogeneity and tissue lipids. , 2007, The Journal of clinical investigation.

[46]  M. Mayr,et al.  Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. , 1987, The Journal of clinical investigation.

[47]  Y. Shimada,et al.  Formation of the epicardium studied with the scanning electron microscope. , 1978, Developmental biology.

[48]  T. Bivalacqua,et al.  Vasoactive prostanoids are generated from arachidonic acid by COX-1 and COX-2 in the mouse. , 2005, American journal of physiology. Heart and circulatory physiology.

[49]  D. Corradi,et al.  The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[50]  P. Meda,et al.  Production of Chemokines by Perivascular Adipose Tissue: A Role in the Pathogenesis of Atherosclerosis? , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[51]  M. Cramer,et al.  Epicardial adipose tissue imaged by magnetic resonance imaging: an important risk marker of cardiovascular disease , 2006, Heart.

[52]  T Ishii,et al.  The effects of a myocardial bridge on coronary atherosclerosis and ischaemia , 1998, The Journal of pathology.

[53]  Marc Sirol,et al.  Neovascularization in Human Atherosclerosis , 2006, Circulation.

[54]  Samin K. Sharma,et al.  Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. , 2000, Circulation.

[55]  J. Flier,et al.  Adipose Tissue as an Endocrine Organ , 2014 .

[56]  B. W. Bakkum The Developing Human: Clinically Oriented Embryology, 7th ed. , 2003 .

[57]  P. Libby,et al.  Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. , 2007, The Journal of clinical investigation.

[58]  C. Stehouwer,et al.  “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease , 2005, The Lancet.

[59]  F. Leonetti,et al.  Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. , 2003, The Journal of clinical endocrinology and metabolism.

[60]  M. Gollasch,et al.  Paracrine role for periadventitial adipose tissue in the regulation of arterial tone. , 2004, Trends in pharmacological sciences.

[61]  J. McGavock,et al.  Adiposity of the Heart*, Revisited , 2006, Annals of Internal Medicine.

[62]  R. Leibel,et al.  CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.

[63]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[64]  M. Lombardi,et al.  Visceral Fat in Hypertension: Influence on Insulin Resistance and β-Cell Function , 2004, Hypertension.

[65]  C. Roobottom,et al.  Intramyocardial bridging of the left anterior descending artery: appearance of arterial compression on ECG gated multidetector row CT , 2006, Heart.

[66]  R. Bonser,et al.  Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease , 2006, Cardiovascular diabetology.

[67]  M. Fiore,et al.  Atherosclerotic lesions: Possible interactive involvement of intima, adventitia and associated adipose tissue , 2000 .

[68]  P. Trayhurn Endocrine and signalling role of adipose tissue: new perspectives on fat. , 2005, Acta physiologica Scandinavica.

[69]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[70]  R. Simsolo,et al.  The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.

[71]  H. Ginsberg Insulin resistance and cardiovascular disease. , 2000, The Journal of clinical investigation.

[72]  R. Virmani,et al.  Sudden death as a result of heart disease in morbid obesity. , 1995, American heart journal.

[73]  Y. Yoon,et al.  All in the family: VEGF-B joins the ranks of proangiogenic cytokines. , 2003, Circulation research.

[74]  F. Leonetti,et al.  Epicardial adipose tissue and insulin resistance in obese subjects. , 2005, The Journal of clinical endocrinology and metabolism.

[75]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[76]  F. Leonetti,et al.  Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. , 2005, Cytokine.

[77]  J. Wilcox,et al.  Perivascular Inflammation After Balloon Angioplasty of Porcine Coronary Arteries , 2001, Circulation.

[78]  H. Kolb,et al.  Production and release of macrophage migration inhibitory factor from human adipocytes. , 2005, Endocrinology.

[79]  P. Angelini,et al.  Anomalous coronary artery arising from the opposite sinus: descriptive features and pathophysiologic mechanisms, as documented by intravascular ultrasonography. , 2003, The Journal of invasive cardiology.

[80]  J. Takasu,et al.  Pericardial fat accumulation in men as a risk factor for coronary artery disease. , 2001, Atherosclerosis.

[81]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[82]  V. Schejbal [Epicardial fatty tissue of the right ventricle--morphology, morphometry and functional significance]. , 1989, Pneumologie.

[83]  S. Tyagi,et al.  Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation , 2004, Cardiovascular Diabetology.

[84]  F. Tacke,et al.  Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. , 2007, The Journal of clinical investigation.

[85]  S. Kihara,et al.  Adiponectin and Metabolic Syndrome , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[86]  Arya M. Sharma,et al.  Adiposity of the heart. , 2006, Annals of internal medicine.

[87]  A. Takeshita,et al.  Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. , 1996, The Journal of clinical investigation.

[88]  K. Wellen,et al.  Obesity-induced inflammatory changes in adipose tissue. , 2003, The Journal of clinical investigation.

[89]  Sonia Caprio,et al.  Obesity and the metabolic syndrome in children and adolescents. , 2004, The New England journal of medicine.

[90]  Cynthia J. Girman,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[91]  C. Pond,et al.  Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. , 1989, Comparative biochemistry and physiology. B, Comparative biochemistry.

[92]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[93]  V. Fuster,et al.  New aspects in the pathogenesis of diabetic atherothrombosis. , 2004, Journal of the American College of Cardiology.

[94]  L. Aloe,et al.  Subepicardial adipose tissue in human coronary atherosclerosis: another neglected phenomenon. , 2001, Atherosclerosis.

[95]  Sue E. Huether,et al.  Pathophysiology: The Biologic Basis for Disease in Adults and Children , 1990 .